InvivoGen (France)

Recent papers from InvivoGen (France)

1. A Chlamydia trachomatis CPAF-STING agonist conjugate vaccine administered intramuscularly and intradermally is immunogenic in the pig modelFrontiers in Immunology · 2026
2. The Defined TLR3 Agonist, Nexavant, Exhibits Anti-Cancer Efficacy and Potentiates Anti-PD-1 Antibody Therapy by Enhancing Immune Cell InfiltrationCancers · 2023
3. STING activation counters glioblastoma by vascular alteration and immune surveillanceCancer Letters · 2023
4. The defined TLR3 agonist, Nexavant, exhibits anti-cancer efficacy and potentiates anti-PD-1 antibody therapy by enhancing immune cell infiltration2023
5. STING activation counters glioblastoma by vascular alteration and immune surveillance2023
6. EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruptionThe Journal of Experimental Medicine · 2023
7. Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancerMolecular Therapy — Methods & Clinical Development · 2023
8. EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption upon Pseudomonas infection2023
9. Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancer2022
10. Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-DependentVaccines · 2022
11. New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responsesEBioMedicine · 2020
12. The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cellsJCI Insight · 2019
13. Proteo-Transcriptomic Dynamics of Cellular Response to HIV-1 InfectionScientific Reports · 2019
14. Deciphering the molecular basis of mycobacteria and lipoglycan recognition by the C-type lectin Dectin-2Scientific Reports · 2018
15. Gαi Signaling Promotes Marginal Zone B Cell Development by Enabling Transitional B Cell ADAM10 ExpressionFrontiers in Immunology · 2018
16. STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in micePLoS Pathogens · 2018
17. Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipidsProceedings of the National Academy of Sciences · 2017
18. Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune ResponsesThe Journal of Immunology · 2017
19. Rational design of adjuvants targeting the C-type lectin MincleProceedings of the National Academy of Sciences · 2017
20. Design, Synthesis, and Biological Evaluation of Novel Cyclic Adenosine–Inosine Monophosphate (cAIMP) Analogs That Activate Stimulator of Interferon Genes (STING)Journal of Medicinal Chemistry · 2016